ArticleCell death & disease2023

Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors.

Eunji Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.